The deal size was increased to $107.5M in common stock from $100M in common stock and priced within the $17.00-$18.00 range. TD Cowen, Guggenheim and Oppenheimer acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on URGN:
- UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
- UroGen Pharma price target raised to $40 from $32 at Oppenheimer
- UroGen Pharma price target raised to $53.50 from $48 at Ladenburg
- UroGen Pharma price target raised to $60 from $54 at H.C. Wainwright
- UroGen Pharma trading resumes
Questions or Comments about the article? Write to editor@tipranks.com